EBV-LMP1-targeted DNAzyme induces DNA damage and causes cell cycle arrest in LMP1-positive nasopharyngeal carcinoma cells

Ma,Xiaoqian; Xu,Zhijie; Yang,Lifang; Xiao,Lanbo; Tang,Min; Lu,Jingchen; Xu,San; Tang,Yiping; Wen,Xinxian; Deng,Xingming; Sun,Lunquan; Cao,Ya

doi:10.3892/ijo.2013.2098

EBV-LMP1-targeted DNAzyme induces DNA damage and causes cell cycle arrest in LMP1-positive nasopharyngeal carcinoma cells

Authors:
- Xiaoqian Ma
- Zhijie Xu
- Lifang Yang
- Lanbo Xiao
- Min Tang
- Jingchen Lu
- San Xu
- Yiping Tang
- Xinxian Wen
- Xingming Deng
- Lunquan Sun
- Ya Cao
View Affiliations

Affiliations: Cancer Research Institute, Xiangya School of Medicine, Central South University, Changsha, Hunan 410078, P.R. China, Department of Radiation Oncology, Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA, Center for Molecular Medicine, Xiangya Hospital, Central South University, Changsha, Hunan 410078, P.R. China
Published online on: September 13, 2013 https://doi.org/10.3892/ijo.2013.2098
Pages: 1541-1548

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

This study aimed to determine the molecular mechanisms underlying the effect of the LMP1-targeted DNAzyme 1 (DZ1) on cell cycle progression in nasopharyngeal carcinoma (NPC) cells. We showed that the active DZ1 inhibited the expression of latent membrane protein 1 (LMP1) and induced a G1 phase arrest. In addition, this cell cycle deregulation was shown to be accompanied by upregulation of the DNA damage marker γ-H2AX, downregulation of the DNA damage response factor p-p53-Ser15 and cell proliferation inhibition. To investigate what affected the cell cycle progression, we examined the expression of two checkpoint-related cyclins and cyclin-dependent kinases (CDKs). We found a decrease of cyclin D1 and cyclin E protein levels at 24 h from the DZ1 treatment. Moreover, we observed inhibition of CDK4 activity and decreased cyclin D1 expression in the complexes immunoprecipitated with CDK4 antibody. We also found a reduction in cdc2 phosphorylation at Thr161 which partially stands for the cdc2 kinase activity in DZ1-treated CNE1-LMP1 cells, although the downregulation of LMP1 expression had no effect on the cyclin B1 and cdc2 expression. Further, we analyzed changes in cdc2 kinase activity induced by DZ1 and found that the downregulation of the LMP1 expression resulted in a 5-fold reduction in cdc2 kinase activity in CNE1-LMP1. The data suggest that the downregulation of the LMP1 expression by DZ1 was able to induce DNA damage, which then further inhibited the cell proliferation and resulted in malfunction of cell cycle checkpoints that led to G1 phase arrest and the decrease in number of cells in G2/M phase.

View Figures

View References

1.	Ponce RA, Gelzleichter T, Haggerty HG, et al: Immunomodulation and lymphoma in humans. J Immunotoxicol. Jun 7–2013.(Epub ahead of print).
2.	Ghosh SK, Perrine SP, Williams RM and Faller DV: Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents. Blood. 119:1008–1017. 2012. View Article : Google Scholar
3.	Brocqueville G, Ndour PA, Ouk TS, et al: LMP1-induced cell death may contribute to the emergency of its oncogenic property. PLoS One. 8:e607432013. View Article : Google Scholar : PubMed/NCBI
4.	Smuk G, Illes A, Keresztes K, et al: Pheno- and genotypic features of Epstein-Barr virus associated B-cell lymphoproliferations in peripheral T-cell lymphomas. Pathol Oncol Res. 16:377–383. 2010. View Article : Google Scholar : PubMed/NCBI
5.	Diduk SV, Smirnova KV, Pavlish OA and Gurtsevitch VE: Functionally significant mutations in the Epstein-Barr virus LMP1 gene and their role in activation of cell signaling pathways. Biochemistry (Mosc). 73:1134–1139. 2008. View Article : Google Scholar : PubMed/NCBI
6.	Everly DN Jr, Mainou BA and Raab-Traub N: The ID proteins contribute to the growth of rodent fibroblasts during LMP1-mediated transformation. Virology. 376:258–269. 2008. View Article : Google Scholar : PubMed/NCBI
7.	Wu ZZ, Chow KP, Kuo TC, Chang YS and Chao CC: Latent membrane protein 1 of Epstein-Barr virus sensitizes cancer cells to cisplatin by enhancing NF-kappaB p50 homodimer formation and downregulating NAPA expression. Biochem Pharmacol. 82:1860–1872. 2011. View Article : Google Scholar : PubMed/NCBI
8.	Lu JH, Tang YL, Yu HB, et al: Epstein-Barr virus facilitates the malignant potential of immortalized epithelial cells: from latent genome to viral production and maintenance. Lab Invest. 90:196–209. 2010. View Article : Google Scholar : PubMed/NCBI
9.	Gan R, Xie X, He J, et al: Gene analysis of Epstein-Barr virus-associated lymphomas in Hu-Pbl/SCID chimeras. Tumori. 96:465–472. 2010.PubMed/NCBI
10.	Arcipowski KM and Bishop GA: TRAF binding is required for a distinct subset of in vivo B cell functions of the oncoprotein LMP1. J Immunol. 189:5165–5170. 2012. View Article : Google Scholar : PubMed/NCBI
11.	Yoshizaki T, Kondo S, Wakisaka N, et al: Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma. Cancer Lett. 337:1–7. 2013. View Article : Google Scholar : PubMed/NCBI
12.	Zheng H, Li LL, Hu DS, Deng XY and Cao Y: Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Cell Mol Immunol. 4:185–196. 2007.PubMed/NCBI
13.	Tao YG, Tan YN, Liu YP, et al: Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent manner. Cell Signal. 16:781–790. 2004. View Article : Google Scholar
14.	Wang Z, Luo F, Li L, et al: STAT3 activation induced by Epstein-Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 And ERK signaling. Eur J Cancer. 46:2996–3006. 2010. View Article : Google Scholar
15.	Horikawa T, Yang J, Kondo S, et al: Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma. Cancer Res. 67:1970–1978. 2007. View Article : Google Scholar
16.	Dawson CW, Laverick L, Morris MA, Tramoutanis G and Young LS: Epstein-Barr virus-encoded LMP1 regulates epithelial cell motility and invasion via the ERK-MAPK pathway. J Virol. 82:3654–3664. 2008. View Article : Google Scholar : PubMed/NCBI
17.	Sheu LF, Chen A, Wei YH, et al: Epstein-Barr virus LMP1 modulates the malignant potential of gastric carcinoma cells involving apoptosis. Am J Pathol. 152:63–74. 1998.PubMed/NCBI
18.	Li G, Li XP, Peng Y, Liu X and Li XH: Effect of inhibition of EBV-encoded latent membrane protein-1 by small interfering RNA on EBV-positive nasopharyngeal carcinoma cell growth. Di Yi Jun Yi Da Xue Xue Bao. 24:241–246. 2004.PubMed/NCBI
19.	Li XP, Li G, Peng Y, Kung HF and Lin MC: Suppression of Epstein-Barr virus-encoded latent membrane protein-1 by RNA interference inhibits the metastatic potential of nasopharyngeal carcinoma cells. Biochem Biophys Res Commun. 315:212–218. 2004. View Article : Google Scholar
20.	Ndour PA, Brocqueville G, Ouk TS, et al: Inhibition of latent membrane protein 1 impairs the growth and tumorigenesis of latency II Epstein-Barr virus-transformed T cells. J Virol. 86:3934–3943. 2012. View Article : Google Scholar : PubMed/NCBI
21.	Yang L, Lu Z, Ma X, Cao Y and Sun LQ: A therapeutic approach to nasopharyngeal carcinomas by DNAzymes targeting EBV LMP-1 gene. Molecules. 15:6127–6139. 2010. View Article : Google Scholar : PubMed/NCBI
22.	Lu ZX, Ma XQ, Yang LF, et al: DNAzymes targeted to EBV-encoded latent membrane protein-1 induce apoptosis and enhance radiosensitivity in nasopharyngeal carcinoma. Cancer Lett. 265:226–238. 2008. View Article : Google Scholar : PubMed/NCBI
23.	Glaser R, Zhang HY, Yao KT, et al: Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proc Natl Acad Sci USA. 86:9524–9528. 1989. View Article : Google Scholar : PubMed/NCBI
24.	Zhao Y, Tao YG, Luo FJ, Tang FQ, Tang M and Cao Y: Interference effect of epigallocatechin-3-gallate on targets of nuclear factor kappaB signal transduction pathways activated by EB virus encoded latent membrane protein 1. Int J Biochem Cell Biol. 36:1473–1481. 2004.
25.	Benimetskaya L, Takle GB, Vilenchik M, Lebedeva I, Miller P and Stein CA: Cationic porphyrins: novel delivery vehicles for antisense oligodeoxynucleotides. Nucleic Acids Res. 26:5310–5317. 1998. View Article : Google Scholar : PubMed/NCBI
26.	Lu ZX, Ye M, Yan GR, et al: Effect of EBV LMP1 targeted DNAzymes on cell proliferation and apoptosis. Cancer Gene Ther. 12:647–654. 2005. View Article : Google Scholar : PubMed/NCBI
27.	Sugimoto M, Martin N, Wilks DP, et al: Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1). Oncogene. 21:8067–8074. 2002. View Article : Google Scholar : PubMed/NCBI
28.	Ling S and Lin WC: EDD inhibits ATM-mediated phosphorylation of p53. J Biol Chem. 286:14972–14982. 2011. View Article : Google Scholar : PubMed/NCBI
29.	Kitagawa M, Higashi H, Jung HK, et al: The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J. 15:7060–7069. 1996.PubMed/NCBI
30.	Hansen U, Owens L and Saxena UH: Transcription factors LSF and E2Fs: tandem cyclists driving G0 to S? Cell Cycle. 8:2146–2151. 2009. View Article : Google Scholar : PubMed/NCBI
31.	Zhang XH, Zou ZQ, Xu CW, Shen YZ and Li D: Myricetin induces G2/M phase arrest in HepG2 cells by inhibiting the activity of the cyclin B/Cdc2 complex. Mol Med Rep. 4:273–277. 2011.PubMed/NCBI
32.	Tan M, Jing T, Lan KH, et al: Phosphorylation on tyrosine-15 of p34(Cdc2) by ErbB2 inhibits p34(Cdc2) activation and is involved in resistance to taxol-induced apoptosis. Mol Cell. 9:993–1004. 2002. View Article : Google Scholar : PubMed/NCBI
33.	Dawson CW, Port RJ and Young LS: The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC). Semin Cancer Biol. 22:144–153. 2012. View Article : Google Scholar : PubMed/NCBI
34.	Tulalamba W and Janvilisri T: Nasopharyngeal carcinoma signaling pathway: an update on molecular biomarkers. Int J Cell Biol. 2012:5946812012. View Article : Google Scholar : PubMed/NCBI
35.	Mei YP, Zhou JM, Wang Y, et al: Silencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cells. Cell Cycle. 6:1379–1385. 2007. View Article : Google Scholar
36.	Korotayev K, Chaussepied M and Ginsberg D: ERK activation is regulated by E2F1 and is essential for E2F1-induced S phase entry. Cell Signal. 20:1221–1226. 2008. View Article : Google Scholar : PubMed/NCBI
37.	Deng L, Yang J, Zhao XR, et al: Cells in G2/M phase increased in human nasopharyngeal carcinoma cell line by EBV-LMP1 through activation of NF-kappaB and AP-1. Cell Res. 13:187–194. 2003. View Article : Google Scholar : PubMed/NCBI
38.	Zhao XR, Gu HH, Weng XX, Yi W, Deng XY and Cao Y: The primary study on expression and function of D-type cyclins in nasopharyngeal carcinoma cell lines. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 32:192–196. 2000.PubMed/NCBI
39.	Liu DX and Greene LA: Neuronal apoptosis at the G1/S cell cycle checkpoint. Cell Tissue Res. 305:217–228. 2001. View Article : Google Scholar : PubMed/NCBI
40.	Tao D, Wu J, Feng Y, Qin J, Hu J and Gong J: New method for the analysis of cell cycle-specific apoptosis. Cytometry A. 57:70–74. 2004. View Article : Google Scholar : PubMed/NCBI
41.	Agarwal C, Dhanalakshmi S, Singh RP and Agarwal R: Inositol hexaphosphate inhibits growth and induces G1 arrest and apoptotic death of androgen-dependent human prostate carcinoma LNCaP cells. Neoplasia. 6:646–659. 2004. View Article : Google Scholar
42.	Ma X, Yang L, Xiao L, et al: Down-regulation of EBV-LMP1 radio-sensitizes nasal pharyngeal carcinoma cells via NF-kappaB regulated ATM expression. PLoS One. 6:e246472011. View Article : Google Scholar : PubMed/NCBI